NCT00667095 - Over Active Bladder Instillation Study - Botox | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Overactive BladderUrinary Urge IncontinenceUrinary IncontinenceDetrusor HyperreflexiaUrge Incontinence

Interventions

DRUG

Botox Instillation

Botox instilled into the bladder via ureteral catheter and retained for up to 30 minutes then spontaneously voided.

DRUG

DMSO Instillation

DMSO 50% w/w aqueous solution; 50 cubic centimeters instilled into the bladder via ureteral catheter and retained up to 30 minutes then spontaneously voided.

Trial Locations (1)

32224

Mayo Clinic, Jacksonville